Damage-associated molecular patterns and immune activation in bipolar disorder
Objective Immune activation in bipolar disorder (BD) has been frequently reported. Damage‐associated molecular patterns (DAMPs) are key players in the immune activation reaction. The aim of this study was to assess DAMP levels in drug‐free patients with BD during acute episodes. Method Serum levels...
Saved in:
Published in | Acta psychiatrica Scandinavica Vol. 132; no. 3; pp. 211 - 217 |
---|---|
Main Authors | , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.09.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 0001-690X 1600-0447 1600-0447 |
DOI | 10.1111/acps.12417 |
Cover
Loading…
Summary: | Objective
Immune activation in bipolar disorder (BD) has been frequently reported. Damage‐associated molecular patterns (DAMPs) are key players in the immune activation reaction. The aim of this study was to assess DAMP levels in drug‐free patients with BD during acute episodes.
Method
Serum levels of a predetermined set of DAMPs were assessed in drug‐free patients with BD (n = 20) during an acute mood episode. We also included two control groups: healthy subjects, used as a negative control (n = 20); and patients with sepsis, used as a positive control for severe immune activation (n = 20).
Results
Multivariate analysis using generalized linear mixed model indicated that all DAMPs differed as a function of group membership after controlling for age and addressing multiplicity (P < 0.0006 for all comparisons). Follow‐up analyses showed higher levels in BD subjects of circulating cell‐free (ccf) nuclear (n)DNA (P = 0.02), HSP70 (P = 0.03) and HSP90α (P = 0.02) as compared to healthy subjects. Also, patients with BD showed lower levels of ccf nDNA (P = 0.04), HSP60 (P = 0.03), HSP70 (P = 0.01), and HSP90α (P = 0.002) as compared to patients with sepsis and higher levels of ccf mitochondrial DNA (P < 0.0001).
Conclusion
The present findings may be linked to the inflammatory activity previously described among patients with BD and may help in the development of more targeted and personalized treatments for patients under acute episodes of BD. |
---|---|
Bibliography: | L'Oréal Brasil, Academia Brasileira de Ciências Janssen-Cilag NARSAD National Counsel of Technological and Scientific Development (CNPq) Eli Lilly Stanley Medical Research Institute istex:7A0AFC2443052EEF0E153AD9DF5D9071F740A239 CNPq/INCT-TM CNPq-Universal Comissão Nacional da UNESCO ark:/67375/WNG-D98BHB0B-K Programa Ciência sem Fronteiras, modalidade Atração de Jovens Talentos CNPq productivity award II For Women in Science ArticleID:ACPS12417 Coordination for the Improvement of Higher Education Personnel (CAPES), Brazil FIPE-HCPA AstraZeneca Servier ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 0001-690X 1600-0447 1600-0447 |
DOI: | 10.1111/acps.12417 |